KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $6,000 | -71.4% | 536 | -73.6% | 0.00% | – |
Q1 2021 | $21,000 | -88.3% | 2,034 | -81.7% | 0.00% | – |
Q4 2020 | $179,000 | +280.9% | 11,112 | +241.3% | 0.00% | – |
Q3 2020 | $47,000 | -82.3% | 3,256 | -76.9% | 0.00% | – |
Q2 2020 | $266,000 | +83.4% | 14,100 | +86.5% | 0.00% | – |
Q4 2019 | $145,000 | +190.0% | 7,559 | +46.7% | 0.00% | – |
Q3 2019 | $50,000 | +72.4% | 5,154 | +8.1% | 0.00% | – |
Q2 2019 | $29,000 | +383.3% | 4,770 | +599.4% | 0.00% | – |
Q4 2018 | $6,000 | 0.0% | 682 | +103.6% | 0.00% | – |
Q3 2018 | $6,000 | 0.0% | 335 | -2.6% | 0.00% | – |
Q2 2018 | $6,000 | -95.9% | 344 | -97.9% | 0.00% | – |
Q2 2017 | $148,000 | -29.5% | 16,318 | 0.0% | 0.00% | – |
Q1 2017 | $210,000 | +39.1% | 16,318 | 0.0% | 0.00% | – |
Q4 2016 | $151,000 | -5.0% | 16,318 | 0.0% | 0.00% | – |
Q3 2016 | $159,000 | +5200.0% | 16,318 | +5469.3% | 0.00% | – |
Q1 2016 | $3,000 | -50.0% | 293 | -32.3% | 0.00% | – |
Q4 2015 | $6,000 | +500.0% | 433 | +397.7% | 0.00% | – |
Q3 2015 | $1,000 | -50.0% | 87 | +17.6% | 0.00% | – |
Q2 2015 | $2,000 | 0.0% | 74 | 0.0% | 0.00% | – |
Q1 2015 | $2,000 | -33.3% | 74 | 0.0% | 0.00% | – |
Q4 2014 | $3,000 | -66.7% | 74 | -63.0% | 0.00% | – |
Q2 2014 | $9,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |